Attention Deficit with Hyperactivity and Impulsivity (Attention Deficit Hyperativity Disorder, DSM-IV codes 314.01 and 314.00) in children and adolescents ( 6-15 year-olds), In Dutch: Kinderen en adolescenten (6-15 jaar) met ongecompliceerde (= zonder somatische en/of psychiatrische comorbiditeit en ernstige gezinsproblemen) aandachtstekortstoornis met hyperactiviteit en impulsiviteit (DSM IV codes: 314.01 and 314.00).
Conditions
Interventions
Implementation intervention. The ADHD implementation program, which has been successfully pilot tested in Nijmegen, focuses on children and adolescents with uncomplicated ADHD. It has two key componen
and enhanced collaboration between psychiatry and general practitioners, by providing short online courses for the GPs of referred patients. To make this intervention as recommended by the multidiscip
2. Short procedures for diagnostic process (shorter than current usual care)
4. Start and monitoring of pharmaceutical treatment and follow-up of the treatment results, by the child psychiatrist (usual care) or GP (intervention group) (changed 19-sep-2014)
5. Focused parent tr
2. When necessary an extended developmental anamnese, neuropsychological assessment, family assessment and contact with school about the school functioning of the child
3. After these assessements there will be an appointment with the child and adolescent psychiatrist who will explain the
Sponsors
Karakter en Radboud Universitair Medisch Centrum Nijmegen
Eligibility
Inclusion criteria
Inclusion criteria: Children and adolescents (age 6-18 years) with, at referral by their GP, suspicion of uncomplicated ADHD (Attention Deficit Hyperactivity Disorder, DSM-IV codes 314.01 and 314.00).
Exclusion criteria
Exclusion criteria: Children and adolescents (age 6-18 years) with, at referral tot University Cluster of Karakter by their GP, suspicion of uncomplicated ADHD (Attention Deficit Hyperactivity Disorder, DSM-IV codes 314.01 and 314.00) but who appear, after further study of their characteristics and complaints by the admission-coordinator, to have a more complicated (e.g. with psychiatrical or somatic co-morbidity and/of serious family-problems) form of AHDH.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome: Time between referral to the mental health centre and start of treatment. We will examine: 1. Duration of waiting time, between referral and actual start of the diagnostic process; 2. Duration of run time/lead time of the diagnosis and the start of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. ADHD status: The functional status of the patients will be measured with the HoNOSCA. The HoNOSCA provides a global measure of an individuals current mental health status. Time Points: T1,T2,T4,T5,T7; 2. Treatment adherence is measured by using the Morisky Adherence Scale to provide a brief screening measurement of adherence with treatment response options. To measure the treatment adherence regarding the parent training, their appearance will be registered and parents will be asked ( by a brief, self-composed questionnaire at the end of the training) if they consider the parent-training useful and to what extend they apply what they learned in this training. Timepoints: T5, T6, T7; 3. Parents and patients are asked about their experiences (using the Trimbos Thermometer), study and control group are compared. Timepoints: T3 and T7; 4. Semi-strucured telephone interviews with GPs in the study group are done to assess their experiences with the ADHD-program. Focus will be on: A. Their opinion and experience with respect to the referral process (forth and back), compared to usual care; B. Do the involved GPs (in the ADHD-program and control group) feel themselves competent enough to prescribe abd monitor ADHD-medication? C. Do the GPs involved in the ADHD-program think that the course, given by our ADHD-specialist, about prescribing and monitoring medication for ADHD is effective? Is their a difference in their feeling of competence before and after the course? Semi-structured interviews with the involved professionals in the Karakter University Cluster regarding their experiences in this program, with particularly respect to the referral proces between general practitioners and specialists, compared to care as usual. Timepoint: T7; 5. The clinical indicator measuring the ADHD symptoms before and after treatment by using the ADHD-Ratingscale Timepoints: T1, T2, T4, T5, T7; 6. Economic evaluation: Objectives: The economic evaluation aims to determine | — |
Contacts
Public ContactMijnke M.M. Janssen
Reinier Postlaan 12
Outcome results
None listed